Phoenix Asia Holdings Limited Ordinary Shares

PHOE

Phoenix Asia Holdings Limited is a company focused on providing investment and financial services in the Asia region. It engages in asset management, investment advisory, and related activities, aiming to capitalize on market opportunities within Asia. The company's operations include managing funds and offering financial solutions to clients across various sectors.

$31.32 +5.48 (22.14%)
🚫 Phoenix Asia Holdings Limited Ordinary Shares does not pay dividends

Company News

Phoenix Asia Holdings (PHOE) Stock Surges Over 47% After Hours: Here's Why
Benzinga • Mohd Haider • May 8, 2026

Phoenix Asia Holdings announced a $1 billion stock acquisition agreement to acquire clinical-stage pharmaceutical firm ACEA Pharma Inc., marking a strategic pivot from construction into oncology and autoimmune drug development. The stock surged 47.43% in after-hours trading to $28.10, though it closed the regular session down 33.36% at $19.06. Th...

Why Is Phoenix Asia Stock Gaining Today?
Benzinga • Nabaparna Bhattacharya • May 7, 2026

Phoenix Asia Holdings (NASDAQ: PHOE) stock gained 0.19% on Thursday following the announcement of a $1 billion acquisition agreement to purchase 100% of ACEA Pharma, Inc. through the issuance of 100 million shares at $10 each. The deal is expected to close by end of Q2 2026 and marks the company's expansion into the pharmaceutical sector while ma...

Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
GlobeNewswire Inc. • Na • May 5, 2026

Scilex Holding Company announced that its subsidiaries ACEA Therapeutics and ACEA Pharma entered into a definitive agreement to sell 100% of ACEA Pharma's equity to Phoenix Asia Holdings Limited for $1 billion in newly-issued shares. Upon closing, Phoenix will be renamed ACEA Pharma and listed on Nasdaq, with ACEA Thera retaining approximately 82...

Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
Benzinga • Na • May 5, 2026

Scilex Holding Company's subsidiaries ACEA Therapeutics and ACEA Pharma have entered into a definitive stock acquisition agreement with Phoenix Asia Holdings Limited. Under the deal, ACEA will transfer 100% of ACEA Pharma's equity to Phoenix in exchange for 100 million newly-issued ordinary shares at $10 per share, valuing the transaction at $1 b...

The 33rd China Cycle 2025 Grandly Commence
GlobeNewswire Inc. • Globe Newswire • May 6, 2025

The 33rd China Cycle Expo 2025 opened in Shanghai, showcasing the latest innovations and trends in the global cycling industry. The event featured leading brands, new technologies, and a focus on industry transformation and upgrading.

Related Companies